Status:
NOT_YET_RECRUITING
Fungal Vascular Graft Infections, French Multicenter Retrospective Study
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Fungal Infection
Vascular Grafting
Eligibility:
All Genders
18+ years
Brief Summary
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 univers...
Detailed Description
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Candida spp. is the most frequent fungal agent. Main risk factor is prostheto-digestive fistula. Best t...
Eligibility Criteria
Inclusion
- Patients aged ≥ 18 years old with diagnosis of vascular graft and endograft infections (VGEI) in accordance to MAGIC criteria with diagnosis of proven invasive fungal infection according to EORTC criteria.
- No opposition to re-use data.
Exclusion
- Patient previously treated for fungal VGEI
- Patient with suspected VGEI diagnosis based solely on prosthesis implantation in an infected site
- Poor understanding of French.
- Patient under legal protection.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07143409
Start Date
January 1 2026
End Date
May 1 2027
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France